StemCells, Inc. Plans to Advance to Second Clinical Trial in Batten Disease
April 21, 2010 09:00 ET
|
StemCells, Inc.
PALO ALTO, Calif., April 21, 2010 (GLOBE NEWSWIRE) -- StemCells, Inc. (Nasdaq:STEM) announced today that it has submitted a protocol to the FDA for initiation of a second clinical trial of its...